Literature DB >> 31485994

Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study.

Eun Mi Song1, Ho-Su Lee2, Ye-Jee Kim3, Eun Hye Oh1, Nam Seok Ham1, Jeongseok Kim1, Sung Wook Hwang1, Sang Hyoung Park1, Dong-Hoon Yang1, Byong Duk Ye1, Jeong-Sik Byeon1, Seung-Jae Myung1, Jong Lyul Lee4, Yong Sik Yoon4, Chang Sik Yu4, Suk-Kyun Yang5.   

Abstract

BACKGROUND: Little is known about the natural history of perianal fistulas in Asian populations with Crohn's disease (CD). AIMS: We investigated the incidence and outcomes of perianal CD (pCD) in Korean CD patients.
METHODS: A nationwide population-based cohort of 6265 CD patients diagnosed in 2010-2014 was analyzed to investigate the incidence and outcomes of pCD. The results were validated in a hospital-based cohort of 2923 CD patients diagnosed in 1981-2015. Factors associated with pCD development were analyzed. The incidence and outcomes of pCD were compared between the prebiologic and biologic eras.
RESULTS: pCD occurred in 39.2% of the population-based cohort and 56.1% of the hospital-based cohort during the median follow-up of 4.2 and 8.5 years, respectively. The cumulative incidence of pCD was 40.0% at 5 years after CD diagnosis in the population-based cohort and 62.5% at 20 years in the hospital-based cohort. In multivariate analysis, pCD development was positively associated with male sex, younger age and colonic involvement at diagnosis, early diagnosis, and CD diagnosis in the prebiologic era. The cumulative probability of proctectomy at 10, 20, and 30 years after pCD diagnosis was 2.9%, 12.2%, and 16.2%, respectively. The cumulative incidence of pCD occurring after CD diagnosis and the cumulative probability of proctectomy were significantly lower in the biologic era than in the prebiologic era (p < 0.001 and p = 0.03, respectively).
CONCLUSIONS: Compared with Western patients with CD, Korean patients show a high incidence of pCD but have a low probability of proctectomy, suggesting the favorable course of pCD.

Entities:  

Keywords:  Epidemiology; Inflammatory bowel disease; Perianal fistula; Proctectomy

Mesh:

Year:  2019        PMID: 31485994     DOI: 10.1007/s10620-019-05819-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Authors:  David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  The clinical course of fistulating Crohn's disease.

Authors:  S J Bell; A B Williams; P Wiesel; K Wilkinson; R C G Cohen; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

3.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

4.  Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.

Authors:  Sang Hyoung Park; Suk-Kyun Yang; Soo-Kyung Park; Jong Wook Kim; Dong-Hoon Yang; Kee Wook Jung; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Yong Sik Yoon; Chang Sik Yu; Jin-Ho Kim
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

5.  Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.

Authors:  Kevin W A Göttgens; Steven F G Jeuring; Rosel Sturkenboom; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Daisy M A E Jonkers; Laurents P S Stassen; Ad A M Masclee; Marieke J Pierik; Stéphanie O Breukink
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-05       Impact factor: 2.566

6.  Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Zsofia Czegledi; Tamas Szamosi; Janos Banai; Gyula David; Ferenc Zsigmond; Tunde Pandur; Zsuzsanna Erdelyi; Orsolya Gemela; Janos Papp; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

7.  High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.

Authors:  Laurent Beaugerie; Fabrice Carrat; Stéphane Nahon; Jean-David Zeitoun; Jean-Marc Sabaté; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel; Matthieu Allez; Jean-François Fléjou; Julien Kirchgesner; Magali Svrcek
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-02       Impact factor: 11.382

8.  Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries.

Authors:  Shu Chen Wei
Journal:  Intest Res       Date:  2016-06-27

9.  Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease.

Authors:  P F Vollebregt; A A van Bodegraven; T M L Markus-de Kwaadsteniet; D van der Horst; R J F Felt-Bersma
Journal:  Aliment Pharmacol Ther       Date:  2018-03-09       Impact factor: 8.171

Review 10.  Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.

Authors:  Taku Kobayashi; Tadakazu Hisamatsu; Yasuo Suzuki; Haruhiko Ogata; Akira Andoh; Toshimitsu Araki; Ryota Hokari; Hideki Iijima; Hiroki Ikeuchi; Yoh Ishiguro; Shingo Kato; Reiko Kunisaki; Takayuki Matsumoto; Satoshi Motoya; Masakazu Nagahori; Shiro Nakamura; Hiroshi Nakase; Tomoyuki Tsujikawa; Makoto Sasaki; Kaoru Yokoyama; Naoki Yoshimura; Kenji Watanabe; Miiko Katafuchi; Mamoru Watanabe; Toshifumi Hibi
Journal:  Intest Res       Date:  2018-04-30
View more
  3 in total

1.  Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.

Authors:  Mingming Zhu; Xitao Xu; Qi Feng; Zhe Cui; Tianrong Wang; Yunqi Yan; Zhihua Ran
Journal:  Dig Dis Sci       Date:  2020-06-10       Impact factor: 3.199

2.  Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Jeffrey D McCurdy; Christopher Ma; Vipul Jairath; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

3.  Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease.

Authors:  Jong Lyul Lee
Journal:  Ann Coloproctol       Date:  2019-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.